
AI-generated summary
The amoeba Naegleria fowleri causes a rare but often fatal disease called primary amebic meningoencephalitis. The microorganism lives in warm fresh waters and infects a person through the nose when swimming. Since 2022, four cases of infection have been reported in Israel, two of which were fatal.
A child became infected with the rare amoeba Naegleria fowleri after swimming in Lake Kinneret in northern Israel.
This is the fourth case in the country since 2022, and a nine-year-old boy is in intensive care on a ventilator.
The Israeli Ministry of Health has updated recommendations for the public regarding swimming in Lake Kinneret, recommending limiting exposure of water to the nose as much as possible.
TEL AVIV, September 6 - RIA Novosti. A child became infected with a brain-eating amoeba after swimming in Lake Kinneret in northern Israel, the fourth case of the rare disease diagnosed in the country since 2022, Israel's Health Ministry said on Sunday.
"A nine-year-old boy was hospitalized in serious condition with encephalitis. He is in intensive care on a ventilator. Laboratory tests confirmed suspicions that the boy became ill as a result of infection with a rare amoeba, Naegleria fowleri," the press release said.
According to the department, during the epidemiological investigation it was established that the child was swimming at Kursi Beach on Lake Kinneret about a week before hospitalization.
“The Ministry of Health is updating recommendations for the population regarding swimming in Lake Kinneret. When swimming in Lake Kinneret, it is recommended to limit the entry of water into the nose as much as possible,” the Ministry of Health said, listing a number of recommendations.
According to the US Centers for Disease Control and Prevention, about 400 cases of Naegleria fowleri infection have been reported worldwide. Since 2022, four cases of the disease caused by the amoeba Naegleria fowleri have been diagnosed in Israel. Two of the sick people died.

From January 1, 2027, updated rules for admission to blood donation will come into force in Russia: the list of temporary contraindications has been expanded, including the use of glucocorticosteroids and dermatotropic agents, psoriasis, dermatitis, chronic bronchitis, corneal ulcers, outpatient dental procedures and eye surgeries; the list of permanent contraindications has been clarified with the addition of ICD-10 codes; To register a donor, a passport and SNILS will be required, and the questionnaire, consent and consent to the processing of personal data can be completed electronically with a simple electronic signature; The restriction on the maximum number of donations per year has been lifted (previously no more than five for men and four for women), while the type and possibility of each donation will be determined by the health status of the donor; Electronic documents will be stored for 50 years, paper ones - 30 years.

In Dagestan, four students from the Rainbow private school were hospitalized with an acute intestinal infection. Gross violations of sanitary standards were revealed: lack of medical examinations for catering workers and the sale of foods prohibited for baby food. The prosecutor's office organized an inspection and is monitoring the investigation of the criminal case.

In Dagestan, four students from the Rainbow private school were hospitalized with an acute intestinal infection. Rospotrebnadzor revealed violations of sanitary standards at the catering unit: lack of separation of the flow of dishes, lack of medical examinations for staff and the sale of food prohibited for children. The expected route of transmission is food.

Roszdravnadzor has recalled six batches of the Irish diagnostic drug Omnipaque produced by GE Healthcare due to dangerous metal particles in the bottles.

In Russia, an initiative is being discussed to give women the right to go on maternity leave at any stage of pregnancy. State Duma deputy Tatyana Butskaya noted that this will help expectant mothers during the period of early toxicosis.

Chinese authorities have approved the release to the market of the innovative drug Mprosevir for the treatment of COVID-19, created using artificial intelligence technologies and DNA libraries.